United States Steel & Carnegie Pension Fund Decreased By $22.67 Million Its Honeywell Intl (HON) Holding; Shorts at LA Jolla Pharmaceutical Company (LJPC) Raised By 4.98%

November 15, 2017 - By Louis Casey

LA Jolla Pharmaceutical Company (NASDAQ:LJPC) had an increase of 4.98% in short interest. LJPC’s SI was 3.37M shares in November as released by FINRA. Its up 4.98% from 3.21M shares previously. With 207,400 avg volume, 16 days are for LA Jolla Pharmaceutical Company (NASDAQ:LJPC)’s short sellers to cover LJPC’s short positions. The SI to LA Jolla Pharmaceutical Company’s float is 31.45%. The stock decreased 0.54% or $0.19 during the last trading session, reaching $34.7. About shares traded. La Jolla Pharmaceutical Company (NASDAQ:LJPC) has risen 128.65% since November 15, 2016 and is uptrending. It has outperformed by 111.95% the S&P500.

United States Steel & Carnegie Pension Fund decreased Honeywell Intl Inc (HON) stake by 39.85% reported in 2017Q2 SEC filing. United States Steel & Carnegie Pension Fund sold 170,440 shares as Honeywell Intl Inc (HON)’s stock rose 5.49%. The United States Steel & Carnegie Pension Fund holds 257,292 shares with $34.29M value, down from 427,732 last quarter. Honeywell Intl Inc now has $112.23 billion valuation. The stock increased 0.42% or $0.61 during the last trading session, reaching $147.32. About shares traded. Honeywell International Inc. (NYSE:HON) has risen 17.66% since November 15, 2016 and is uptrending. It has outperformed by 0.96% the S&P500.

La Jolla Pharmaceutical Company is a biopharmaceutical company. The company has market cap of $768.44 million. The Firm is focused on the discovery, development and commercialization of therapies to improve outcomes in patients suffering from life-threatening diseases. It currently has negative earnings. LJPC-501 is its formulation of angiotensin II for the potential treatment of catecholamine-resistant hypotension .

Investors sentiment decreased to 1.81 in Q2 2017. Its down 1.05, from 2.86 in 2017Q1. It dropped, as 20 investors sold La Jolla Pharmaceutical Company shares while 12 reduced holdings. 18 funds opened positions while 40 raised stakes. 23.78 million shares or 8.25% more from 21.97 million shares in 2017Q1 were reported. Eam Investors Ltd Liability Corp reported 22,230 shares or 0.11% of all its holdings. D E Shaw owns 62,680 shares. Hollencrest Securities Ltd Limited Liability Company invested 0.1% in La Jolla Pharmaceutical Company (NASDAQ:LJPC). State Common Retirement Fund has invested 0% in La Jolla Pharmaceutical Company (NASDAQ:LJPC). Alyeska Investment Limited Partnership reported 0.02% of its portfolio in La Jolla Pharmaceutical Company (NASDAQ:LJPC). Tang Capital Mngmt Ltd Co accumulated 3.44 million shares. Axiom International Limited De has 0.04% invested in La Jolla Pharmaceutical Company (NASDAQ:LJPC) for 55,309 shares. The Switzerland-based Swiss National Bank & Trust has invested 0% in La Jolla Pharmaceutical Company (NASDAQ:LJPC). Natl Bank Of America De reported 0% of its portfolio in La Jolla Pharmaceutical Company (NASDAQ:LJPC). Goldman Sachs Group holds 0% or 15,301 shares in its portfolio. 1.26 million were reported by Broadfin Capital Lc. Quantitative Invest Mngmt Ltd Com reported 121,800 shares. Sei Invs, a Pennsylvania-based fund reported 227 shares. Baker Bros Advisors Limited Partnership stated it has 504,732 shares or 0.13% of all its holdings. Airain reported 0.02% stake.

Among 6 analysts covering La Jolla Pharmaceutical Company (NASDAQ:LJPC), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. La Jolla Pharmaceutical Company had 10 analyst reports since August 11, 2015 according to SRatingsIntel. Cowen & Co initiated the shares of LJPC in report on Tuesday, February 9 with “Outperform” rating. Jefferies maintained La Jolla Pharmaceutical Company (NASDAQ:LJPC) rating on Monday, July 24. Jefferies has “Buy” rating and $4000 target. The company was maintained on Monday, June 12 by Jefferies. The stock has “Buy” rating by Chardan Capital Markets on Tuesday, September 8. J.P. Morgan initiated La Jolla Pharmaceutical Company (NASDAQ:LJPC) rating on Wednesday, August 30. J.P. Morgan has “Buy” rating and $36.0 target. Jefferies maintained the shares of LJPC in report on Thursday, August 31 with “Buy” rating. The company was initiated on Tuesday, May 24 by Lake Street. On Tuesday, August 11 the stock rating was downgraded by Zacks to “Hold”.

Among 21 analysts covering Honeywell International Inc. (NYSE:HON), 17 have Buy rating, 0 Sell and 4 Hold. Therefore 81% are positive. Honeywell International Inc. has $170 highest and $7 lowest target. $132.66’s average target is -9.95% below currents $147.32 stock price. Honeywell International Inc. had 76 analyst reports since July 30, 2015 according to SRatingsIntel. Cowen & Co maintained the shares of HON in report on Tuesday, September 12 with “Buy” rating. Oppenheimer maintained Honeywell International Inc. (NYSE:HON) on Tuesday, August 8 with “Buy” rating. On Thursday, September 28 the stock rating was maintained by RBC Capital Markets with “Buy”. The stock of Honeywell International Inc. (NYSE:HON) earned “Buy” rating by Jefferies on Friday, June 30. On Tuesday, October 20 the stock rating was maintained by Argus Research with “Buy”. Stifel Nicolaus maintained it with “Buy” rating and $153.0 target in Thursday, August 24 report. RBC Capital Markets maintained Honeywell International Inc. (NYSE:HON) on Monday, April 24 with “Outperform” rating. The rating was maintained by Credit Suisse on Wednesday, April 12 with “Hold”. The firm has “Buy” rating given on Friday, May 26 by RBC Capital Markets. The stock has “Buy” rating by Oppenheimer on Friday, July 21.

Analysts await Honeywell International Inc. (NYSE:HON) to report earnings on January, 26. They expect $1.85 earnings per share, up 6.32% or $0.11 from last year’s $1.74 per share. HON’s profit will be $1.41B for 19.91 P/E if the $1.85 EPS becomes a reality. After $1.75 actual earnings per share reported by Honeywell International Inc. for the previous quarter, Wall Street now forecasts 5.71% EPS growth.

Since May 19, 2017, it had 0 insider buys, and 2 selling transactions for $16.01 million activity. Adams Katherine L. also sold $15.28M worth of Honeywell International Inc. (NYSE:HON) shares. The insider SHEARES BRADLEY T sold 3,430 shares worth $451,765. Shares for $726,659 were sold by Mak Jennifer H on Tuesday, May 23.

Investors sentiment decreased to 0.96 in 2017 Q2. Its down 0.08, from 1.04 in 2017Q1. It dived, as 58 investors sold HON shares while 492 reduced holdings. 104 funds opened positions while 426 raised stakes. 562.97 million shares or 0.95% less from 568.40 million shares in 2017Q1 were reported. Dowling Yahnke Limited Liability Company holds 50,996 shares. Cahill Fin has 5,152 shares. Bartlett Ltd invested in 12,429 shares. Hartford has 19,446 shares for 1.16% of their portfolio. Sumitomo Mitsui Asset Limited accumulated 0.12% or 57,618 shares. Gam Ag invested in 234,310 shares or 0.46% of the stock. Evercore Trust Na invested in 8.01% or 19.71M shares. Monetary Mngmt Grp has invested 1.37% in Honeywell International Inc. (NYSE:HON). Axiom Intl Investors Limited Liability Corporation De has 1.05% invested in Honeywell International Inc. (NYSE:HON) for 329,750 shares. Seabridge Invest Advsr Limited Liability Company accumulated 26,858 shares. Hudson Valley Invest Advsrs Adv invested in 10,630 shares or 0.39% of the stock. Wade G W & owns 100,695 shares or 1.7% of their US portfolio. Texas Yale Capital stated it has 0.02% in Honeywell International Inc. (NYSE:HON). Proshare Ltd Liability Corp stated it has 93,205 shares. Canandaigua Commercial Bank And Trust accumulated 13,783 shares or 0.38% of the stock.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Louis Casey




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: